Recombinant p35 from bacteria can form interleukin (IL-)12, but not IL-35

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Aparicio Siegmund, Samadhi ^a   Moll, Jens M ^a   Lokau, Juliane ^b   Grusdat, Melanie ^c   Schröder, Jutta ^a   Plöhn, Svenja ^a   Rose John, Stefan ^b   Grötzinger, Joachim ^b   Lang, Philipp A ^c   Scheller, Jürgen ^a   Garbers, Christoph ^a,b  

^a Department of Orthopedic Surgery   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; DISULFIDE; GLYCOPROTEIN GP 130; HETERODIMER; HOMODIMER; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 23; INTERLEUKIN 35; PROTEIN P35; PROTEIN P40; RECOMBINANT P35 PROTEIN; RECOMBINANT PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG; CYTOKINE; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN DERIVATIVE; INTERLEUKIN-35, MOUSE; PROTEIN BINDING; PROTEIN SUBUNIT;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISULFIDE BOND; ESCHERICHIA COLI; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MUTATION; NONHUMAN; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; ANIMAL; CD4+ T LYMPHOCYTE; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; IMMUNOLOGY; METABOLISM; MOUSE; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; PROTEIN SUBUNIT;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CYTOKINES; HUMANS; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P35; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKINS; MICE; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; PROTEIN SUBUNITS; RECOMBINANT PROTEINS;

EID: 84907909046     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107990     Document Type: Article

References (34)

1. Garbers C, Hermanns H, Schaper F, Müller-Newen G, Grötzinger J, et al. (2012) Plasticity and cross-talk of Interleukin 6-type cytokines. Cytokine Growth Factor Rev 23: 85-182.
2. Jones L, Chaturvedi V, Uyttenhove C, Van Snick J, Vignali DA (2012) Distinct subunit pairing criteria within the heterodimeric IL-12 cytokine family. Mol Immunol 51: 234-244.
3. Hölscher C (2004) The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases. Med Microbiol Immunol 193: 1-17.
4. Gillessen S, Carvajal D, Ling P, Podlaski F, Stremlo D, et al. (1995) Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur J Immunol 25: 200-206.
5. Ling P, Gately M, Gubler U, Stern A, Lin P, et al. (1995) Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J Immunol 154: 116-127.
6. Heinzel F, Hujer A, Ahmed F, Rerko R (1997) In vivo production and function of IL-12 p40 homodimers. J Immunol 158: 4381-4388.
7. Shimozato O, Ugai S-i, Chiyo M, Takenobu H, Nagakawa H, et al. (2006) The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects. Immunology 117: 22-28.
8. Presky D, Yang H, Minetti L, Chua A, Nabavi N, et al. (1996) A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci U S A 93: 14002-14007.
9. Parham C, Chirica M, Timans J, Vaisberg E, Travis M, et al. (2002) A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 168: 5699-5708.
10. Collison L, Delgoffe G, Guy C, Vignali K, Chaturvedi V, et al. (2012) The composition and signaling of the IL-35 receptor are unconventional. Nat Immunol 13: 290-299.
11. Collison L, Workman C, Kuo T, Boyd K, Wang Y, et al. (2007) The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450: 566-569.
12. Wang R-XX, Yu C-RR, Dambuza IM, Mahdi RM, Dolinska M, et al. (2014) Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nature medicine.
13. Pflanz S, Hibbert L, Mattson J, Rosales R, Vaisberg E, et al. (2004) WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J Immunol 172: 2225-2231.
14. Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, et al. (2002) IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16: 779-790.
15. Garbers C, Scheller J (2013) Interleukin-6 and interleukin-11: same same but different. Biol Chem 394: 1145-1161.
16. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S (2011) The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 1813: 878-888.
17. Garbers C, Spudy B, Aparicio-Siegmund S, Waetzig GH, Sommer J, et al. (2013) An Interleukin-6 Receptor-dependent Molecular Switch Mediates Signal Transduction of the IL-27 Cytokine Subunit p28 (IL-30) via a gp130 Protein Receptor Homodimer. J Biol Chem 288: 4346-4354.
18. Garbers C, Jänner N, Chalaris A, Moss ML, Floss DM, et al. (2011) Species specificity of ADAM10 and ADAM17 proteins in interleukin-6 (IL-6) trans-signaling and novel role of ADAM10 in inducible IL-6 receptor shedding. J Biol Chem 286: 14804-14811.
19. Fischer M, Goldschmitt J, Peschel C, Brakenhoff JP, Kallen KJ, et al. (1997) I. A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Nat Biotechnol 15: 142-145.
20. Schroers A, Hecht O, Kallen KJ, Pachta M, Rose-John S, et al. (2005) Dynamics of the gp130 cytokine complex: a model for assembly on the cellular membrane. Protein Sci 14: 783-790.
21. Chalaris A, Rabe B, Paliga K, Lange H, Laskay T, et al. (2007) Apoptosis is a natural stimulus of IL6R shedding and contributes to the pro-inflammatory trans-signaling function of neutrophils. Blood 110: 1748-1755.
22. Garbers C, Thaiss W, Jones GW, Waetzig GH, Lorenzen I, et al. (2011) Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor. J Biol Chem 286: 42959-42970.
23. Koch M, May U, Kuhns S, Drechsler H, Adam N, et al. (2007) Interleukin 27 induces differentiation of neural C6-precursor cells into astrocytes. Biochem Biophys Res Commun 364: 483-487.
24. Lieschke GJ, Rao PK, Gately MK, Mulligan RC (1997) Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo. Nat Biotechnol 15: 35-40.
25. Niedbala W, Wei X-Q, Cai B, Hueber A, Leung B, et al. (2007) IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 37: 3021-3029.
26. Shen P, Roch T, Lampropoulou V, O'Connor RA, Stervbo U, et al. (2014) IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 507: 366-370.
27. Oppmann B, Lesley R, Blom B, Timans J, Xu Y, et al. (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13: 715-725.
28. Yoon C, Johnston S, Tang J, Stahl M (2000) Charged residues dominate a unique interlocking topography in the heterodimeric cytokine interleukin-12. EMBO J 19: 3530-3541.
29. Davis S, Aldrich TH, Stahl N, Pan L, Taga T, et al. (1993) LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science 260: 1805-1808.
30. Schuster B, Kovaleva M, Sun Y, Regenhard P, Matthews V, et al. (2003) Signaling of human ciliary neurotrophic factor (CNTF) revisited. The interleukin-6 receptor can serve as an alpha-receptor for CTNF. J Biol Chem 278: 9528-9535.
31. Crabé S, Guay-Giroux A, Tormo AJ, Duluc D, Lissilaa R, et al. (2009) The IL-27 p28 subunit binds cytokine-like factor 1 to form a cytokine regulating NK and T cell activities requiring IL-6R for signaling. J Immunol 183: 7692-7702.
32. Tormo A, Meliani Y, Beaupré L, Sharma M, Fritz J, et al. (2013) The Composite Cytokine p28/Cytokine-Like Factor 1 Sustains B Cell Proliferation and Promotes Plasma Cell Differentiation. J Immunol 191: 1657-1665.
33. Suthaus J, Adam N, Grötzinger J, Scheller J, Rose-John S (2011) Viral Interleukin-6: Structure, pathophysiology and strategies of neutralization. Eur J Cell Biol 90: 495-504.
34. Chalaris A, Garbers C, Rabe B, Rose-John S, Scheller J (2011) The soluble Interleukin 6 receptor: generation and role in inflammation and cancer. Eur J Cell Biol 90: 484-494.